If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
885.00    -3.00 (-0.34%)
Bid:
884.00
Ask:
886.00
Spread: 2.00 (0.226%)
Market Cap: £1.23b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

28 Apr 2020 15:53

RNS Number : 2105L
Savills PLC
28 April 2020
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILIES ('PDMRS')

 

Vesting and Grant of Share Awards

 

Awards made on 18 April 2017 over ordinary shares of the Company under the Company's Deferred Share Plans have now become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustee of The Savills plc 1992 Employee Benefit Trust ('Trustee') effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares which completed on 27 April 2020, to Directors and PDMRS of the Company as detailed in the table below.

 

The Company also announces that on 27 April 2020 the grant of the share based element of 2019 profit share awards was made under the Savills Deferred Share Bonus Plan to Directors and PDMRS of the Company as detailed in the table below.

 

Director / PDMR

Number of Shares Transferred to Director / PDMR by Trustee

Number of Shares sold by Trustee to settle associated tax liabilities

Director / PDMR Shareholding following this notification

Shareholding as a % of issued share capital

Number of Shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR

Beneficial interest under the Deferred Share Plans following this notification

Mark Ridley (Director)

27,360

24,357

210,321

0.15%

85,446

171,611

Simon Shaw (Director)

26,715

23,783

182,579

0.13%

63,821

175,537

Simon Hope (PDMR)

3,693

3,271

190,789

0.13%

5,652

18,781

Chris Lee (PDMR)

7,122

6,343

112,138

0.08%

13,329

37,851

Christian Mancini (PDMR)

8,183

n/a

112,407

0.08%

7,974

26,789

Mitchell Rudin (PDMR)

n/a

n/a

34,158

0.02%

12,811

184,756

James Sparrow (PDMR)

n/a

n/a

58,798

0.04%

35,681

69,140

Mitchell Steir (PDMR)

5,187

5,644

52,500

0.04%

21,488

46,033

 

The share price on disposal of shares to settle associated tax liabilities was £8.823376 per share.

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Simon Hope

4. Chris Lee

5. Christian Mancini

6. Mitchell Rudin

7. James Sparrow

8. Mitchell Steir

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Global Head of Capital Markets/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6. President, Savills US / PDMR

7. Chief Executive Officer UK & EMEA/ PDMR

8. Chairman and CEO - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Vesting of awards under the Company's Deferred Share Plans and sale of shares to settle associated tax liabilities

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Number of Shares Transferred at nil cost by Trustee to Director / PDMR

 

1. 27,360

2. 26,715

3. 3,693

4. 7,122

5. 8,183

6. n/a

7. n/a

8. 5,187

 

Number of Shares sold by Trustee to settle tax liabilities at £8.823376 per share

 

1. 24,357

2. 23,783

3. 3,271

4. 6,343

5. n/a

6. n/a

7. n/a

8. 5,644

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP')

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

1. 85,446

2. 63,821

3. 5,652

4. 13,329

5. 7,974

6. 12,811

7. 35,681

8. 21,488

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

28 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKZGZDDRGGGZM
Date   Source Headline
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding
20th Dec 20191:42 pmRNSChange of External Auditor
12th Dec 20193:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20199:38 amRNSDirector/PDMR Shareholding
2nd Dec 20194:00 pmRNSTotal Voting Rights
2nd Dec 20192:27 pmRNSDirector/PDMR Shareholding
12th Nov 20193:51 pmRNSDirector/PDMR Shareholding
31st Oct 201910:50 amRNSBoard Change
14th Oct 20199:39 amRNSDirector/PDMR Shareholding
1st Oct 20199:00 amRNSTotal Voting Rights
12th Sep 20191:12 pmRNSDirector/PDMR Shareholding
10th Sep 20193:57 pmRNSDirector/PDMR Shareholding
2nd Sep 20195:04 pmRNSTotal Voting Rights
15th Aug 20193:56 pmRNSBlock listing Interim Review
13th Aug 20194:39 pmRNSDirector/PDMR Shareholding
8th Aug 20198:47 amRNSInterim Dividend Record Date Correction
8th Aug 20197:00 amRNSHalf-year Report
22nd Jul 201911:29 amRNSBlock listing Interim Review
18th Jul 20195:20 pmRNSHolding(s) in Company
11th Jul 20194:58 pmRNSDirector/PDMR Shareholding
11th Jun 20192:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20197:00 amRNSTotal Voting Rights
13th May 201912:27 pmRNSDirector/PDMR Shareholding
10th May 20195:02 pmRNSDirector/PDMR Shareholding
8th May 20194:33 pmRNSResult of AGM
8th May 201910:04 amRNSAGM Statement
1st May 20197:00 amRNSTotal Voting Rights
24th Apr 20199:30 amRNSAppointment of New CEO of Savills Investment Mgmt
17th Apr 201912:00 pmRNSIssue of Equity
16th Apr 20193:24 pmRNSDirector/PDMR Shareholding
11th Apr 20194:02 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:06 pmRNSHolding(s) in Company
1st Apr 201912:17 pmRNSAnnual Report and AGM Notice
22nd Mar 20192:22 pmRNSHolding(s) in Company
20th Mar 201912:11 pmRNSHolding(s) in Company
19th Mar 20194:11 pmRNSDirector/PDMR Shareholding
14th Mar 20193:13 pmRNSHolding(s) in Company
14th Mar 20197:00 amRNSFinal Results
12th Mar 20194:46 pmRNSDirector/PDMR Shareholding
6th Mar 20196:03 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
25th Feb 20199:03 amRNSHolding(s) in Company
15th Feb 20197:00 amRNSBlock listing Interim Review
12th Feb 201912:48 pmRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSTotal Voting Rights
21st Jan 201910:55 amRNSBlock listing Interim Review
15th Jan 20197:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.